PTP
VRTX icon

Platform Technology Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Platform Technology Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750K Buy
1,509
+61
+4% +$27K 0.12% 146
2026
Q1 		$647K Buy
1,448
+144
+11% +$67.1K 0.12% 142
2025
Q4 		$591K Buy
1,304
+70
+6% +$30.2K 0.13% 141
2025
Q3 		$483K Hold
1,234
– – 0.12% 153
2025
Q2 		$549K Sell
1,234
-31
-2% -$14.3K 0.14% 143
2025
Q1 		$613K Hold
1,265
– – 0.18% 117
2024
Q4 		$510K Sell
1,265
-1
-0.1% -$464 0.15% 117
2024
Q3 		$588K Sell
1,266
-90
-7% -$43.2K 0.19% 109
2024
Q2 		$636K Buy
+1,356
New +$589K 0.22% 100
2023
Q4 		$576K Sell
1,377
-50
-4% -$18.5K 0.22% 104
2023
Q3 		$496K Hold
1,427
– – 0.23% 99
2023
Q2 		$488K Sell
1,427
-21
-1% -$7.08K 0.23% 102
2023
Q1 		$456K Sell
1,448
-130
-8% -$39K 0.23% 107
2022
Q4 		$456K Hold
1,578
– – 0.24% 105
2022
Q3 		$457K Sell
1,578
-47
-3% -$13.5K 0.26% 99
2022
Q2 		$458K Sell
1,625
-27
-2% -$7.23K 0.25% 103
2022
Q1 		$431K Sell
1,652
-30
-2% -$7.12K 0.21% 117
2021
Q4 		$369K Sell
1,682
-89
-5% -$17.3K 0.16% 142
2021
Q3 		$321K Buy
1,771
+13
+0.7% +$2.54K 0.15% 160
2021
Q2 		$354K Buy
+1,758
New +$368K 0.15% 164
2020
Q4 		$418K Buy
1,769
+331
+23% +$75.9K 0.2% 125
2020
Q3 		$391K Buy
1,438
+18
+1% +$4.97K 0.24% 110
2020
Q2 		$412K Buy
1,420
+5
+0.4% +$1.36K 0.29% 96
2020
Q1 		$337K Buy
1,415
+200
+16% +$45.9K 0.31% 99
2019
Q4 		$266K Buy
+1,215
New +$246K 0.2% 132

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Platform Technology Partners's VRTX Position: Q2 2026 in Review

Platform Technology Partners increased its Vertex Pharmaceuticals (VRTX) stake by 4.2% in Q2 2026, buying an estimated $27K and bringing the position to 1,509 shares worth $750K. The position accounts for 0.12% of the portfolio, ranked #146.

Platform Technology Partners first reported a position in VRTX in Q4 2019 and has held it in 25 quarters since. 1,754 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Platform Technology Partners held 1,509 shares of Vertex Pharmaceuticals worth $750K as of Q2 2026.
  • Platform Technology Partners bought 61 Vertex Pharmaceuticals shares in Q2 2026, an estimated $27K.
  • Vertex Pharmaceuticals made up 0.12% of Platform Technology Partners's portfolio in Q2 2026, its #146 holding.
  • Platform Technology Partners first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 25 quarters since.
  • 1,754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.